At the upcoming IOSICON 2024 Conference, the Society for Immunotherapy of Cancer and the Immuno-Oncology Society of India (I-OSI) will hold a collaborative session on immunotherapy guidelines.
The annual conference, taking place January 12-14, 2024, at National Centre for Cell Science, NCCS Complex, Savitribai Phule Pune University, will highlight the potential of cells, metabolism, and molecules in cancer immunotherapy. The three-day conference is designed to provide scientists and clinicians with a common interest in immuno-oncology the opportunity to interact with current and future leaders from all around the world.
The SITC-I-OSI Collaborative Session on Immunotherapy Guidelines will feature talks on the role of precision medicine and decision making in breast cancer, head and neck squamous cell carcinoma, lung cancer and mesothelioma, and gynecologic cancer guidelines for ICI. Following these talks, there will be a combined panel session focusing on the practical application of immunotherapy guidelines and precision care in solid tumors. The program faculty are listed below, and the full conference agenda can be viewed here.
Program Faculty:
Nora Disis, MD - University of Washington
Robert L. Ferris, MD, PhD - UPMC Hillman Cancer Center
Margaret Gatti-Mays, MD, MPH - Mayo Clinic
Ramaswamy Govindan, MD - Washington University School of Medicine